MIAMI – June 12, 2018 – Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, today launched a new program designed to educate patients and providers on treatment alternatives to opioids available through the company. The campaign is part of the company’s initiative to spread awareness of available alternative therapies that can improve a person’s quality of life and, in many cases, prevent tragedy caused by opioid abuse and solve the nationwide epidemic.
Beginning this month and running in digital and social properties, the campaign is targeted to physicians and patients who have been affected by the opioid epidemic and/or interested in receiving pain management information. The campaign is estimated to reach millions of patients and physicians.
“As one of the few providers in the nation that offers customized opioid alternative solutions for patients, as well as educates physicians on the current best pain management medicinal therapies and custom compound therapies, Progressive Care has a large opportunity to help alleviate the U.S. opioid epidemic,” said S. Parikh Mars, CEO of Progressive Care. “It is a serious issue and continues to cause incredible damage to patients and communities through tragic overdose, detrimental addictive behavior, and increased infectious disease rates. We hope that this program illustrates Progressive Care’s commitment to educating the public on the facts of opioid alternatives and combat this growing problem through available alternative treatments.”
Backed by research statistics, the campaign features declarative statements about the misuse of opioids and the series of options and alternatives for patients and doctors to consider before prescribing an opioid or for patients whose opioid regimen is ineffective or causing harm.
Mars continued: “Through our experienced staff and on-site compounding lab capable of producing both custom oral and topical dosage forms, Progressive Care is in a position to make a real difference in patient health outcomes by not only providing necessary information but also by being a one-stop option for prescription management, especially with therapies and treatments for pain.”
Progressive Care’s wholly owned subsidiary, PharmCo, LLC has the most current pharmacological information, a team of pharmacists and technicians highly trained in pain management and compounding, and offers physician in-services, educational seminars, patient consultation and customized medicinal pain management solutions.
The company worked with Mass Ventures Corp, a Florida-based consulting agency providing app logistics, website production and digital marketing, to develop the program.
Connect and stay in touch with us on social media:
Progressive Care Inc.
About Progressive Care Inc.
Progressive Care Inc. (OTCQB: RXMD), through its PharmCo, LLC, is a South Florida health services organization and provider of prescription pharmaceuticals, compounded medications, provider of tele-pharmacy services, the sale of anti-retroviral medications, medication therapy management (MTM), the supply of prescription medications to long term care facilities, and health practice risk management.
Cautionary Statement Regarding Forward Looking Statements
Statements contained herein that are not based upon current or historical fact are forward-looking in nature and constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements reflect the Company’s expectations about its future operating results, performance and opportunities that involve substantial risks and uncertainties. These statements include but are not limited to statements regarding the intended terms of the offering, closing of the offering and use of any proceeds from the offering. When used herein, the words “anticipate,” “believe,” “estimate,” “upcoming,” “plan,” “target,” “intend” and “expect” and similar expressions, as they relate to Progressive Care Inc., its subsidiaries, or its management, are intended to identify such forward-looking statements. These forward-looking statements are based on information currently available to the Company and are subject to a number of risks, uncertainties, and other factors that could cause the Company’s actual results, performance, prospects, and opportunities to differ materially from those expressed in, or implied by, these forward-looking statements.
Public Relations Contact:
Tory Patterson, CMW Media
Investor Relations Contact:
Armen Karapetyan, Progressive Care
Senior Advisor Business Development